All News
All News Stories
Human clinical trial sites added for cancer drug
December 16, 2014
Advanced Cancer Therapeutics (ACT), a privately held company dedicated to bringing new anti-cancer therapies to market, announced that the University of Texas MD Anderson Cancer Center in Houston and the University of Texas Health Science Center at San Antonio have been added as human clinical trial sites for PFK-158, a first-in-man/first-in-class inhibitor of PFKFB3, an enzyme that controls glycolysis and that is overexpressed in most hematological and solid tumors. The two new clinical trial sites are expected to begin enrolling patients Jan. 1, 2015.
United Nations Ambassador Samantha Power to visit UofL
December 16, 2014
Samantha Power, U.S. ambassador to the United Nations, will speak at the University of Louisville Jan. 12 as a guest of the university’s McConnell Center.